MSI2 is required for maintaining activated myelodysplastic syndrome stem cells
Several studies have recently demonstrated the role of the MSI2 RNA binding protein in normal and malignant haematopoietc stem cells. In this study, the authors show that MSI2 is required for maintaining myelodysplastic syndrome stem cells in mice and that MSI2 expression predicts poor prognosis in...
Enregistré dans:
Auteurs principaux: | James Taggart, Tzu-Chieh Ho, Elianna Amin, Haiming Xu, Trevor S. Barlowe, Alexendar R. Perez, Benjamin H. Durham, Patrick Tivnan, Rachel Okabe, Arthur Chow, Ly Vu, Sun Mi Park, Camila Prieto, Christopher Famulare, Minal Patel, Christopher J. Lengner, Amit Verma, Gail Roboz, Monica Guzman, Virginia M. Klimek, Omar Abdel-Wahab, Christina Leslie, Stephen D. Nimer, Michael G. Kharas |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/3c73f9725b9740dfbe30b10dcaac4d49 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The Caribbean Msi+5 Regional Review
Publié: (2015) -
Clonal evolution in myelodysplastic syndromes
par: Pedro da Silva-Coelho, et autres
Publié: (2017) -
TP53 in Myelodysplastic Syndromes
par: Yan Jiang, et autres
Publié: (2021) -
Managing myelodysplastic symptoms in elderly patients
par: R Ria, et autres
Publié: (2009) -
The genomic landscape of pediatric myelodysplastic syndromes
par: Jason R. Schwartz, et autres
Publié: (2017)